8-K 1 doc1.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 14, 2004 LIFECELL CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 01-19890 76-0172936 (State Or Other (Commission (IRS Employer Jurisdiction Of File Number) Identification No.) Incorporation) One Millenium Way Branchburg, New Jersey 08876 -------------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (908) 947-1100 -1- Item 5. Other Events. Pursuant to the terms of LifeCell Corporation's certificate of incorporation, as of May 14, 2004, all of the outstanding shares of Series B Preferred Stock of LifeCell automatically converted into an aggregate of 1,867,569 shares of common stock of LifeCell. -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIFECELL CORPORATION By: /s/ Steven Sobieski --------------------- Steven T. Sobieski Chief Financial Officer Date: May 24, 2004 -3-